Cargando…

Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark

BACKGROUND: Antipsychotic (AP) medication is increasingly used for many health conditions. Prenatal exposure to AP medication has been associated with several adverse outcomes, but the findings remain inconsistent. PURPOSE: We aimed to investigate prenatal exposure to AP medication and the use of pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Würtz, Anne Mette Lund, Høstrup Vestergaard, Claus, Rytter, Dorte, Sørensen, Merete Juul, Christensen, Jakob, Vestergaard, Mogens, Bech, Bodil Hammer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716673/
https://www.ncbi.nlm.nih.gov/pubmed/29238228
http://dx.doi.org/10.2147/CLEP.S145524
_version_ 1783283997200089088
author Würtz, Anne Mette Lund
Høstrup Vestergaard, Claus
Rytter, Dorte
Sørensen, Merete Juul
Christensen, Jakob
Vestergaard, Mogens
Bech, Bodil Hammer
author_facet Würtz, Anne Mette Lund
Høstrup Vestergaard, Claus
Rytter, Dorte
Sørensen, Merete Juul
Christensen, Jakob
Vestergaard, Mogens
Bech, Bodil Hammer
author_sort Würtz, Anne Mette Lund
collection PubMed
description BACKGROUND: Antipsychotic (AP) medication is increasingly used for many health conditions. Prenatal exposure to AP medication has been associated with several adverse outcomes, but the findings remain inconsistent. PURPOSE: We aimed to investigate prenatal exposure to AP medication and the use of primary health care system in childhood. SUBJECTS AND METHODS: All live-born singletons in Denmark during 1997–2012 were identified in the nationwide Danish National Patient Register and followed until December 31, 2013 (n = 963,010). Information on prenatal exposure to AP medication was obtained from the Danish Register of Medicinal Product Statistics. Contacts to the general practitioner (GP) were used as a proxy for the overall health of the children. Negative binomial regression was used to calculate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for the association between prenatal exposure to AP medication and number and type of GP contacts, excluding routine well-child visits and vaccinations. The models were adjusted for sex and birth date of the child, maternal age, parity, cohabitation status, income, education, smoking status, diagnosis of substance abuse, severe psychiatric disorder, depression and epilepsy as well as the use of antiepileptic drugs, antidepressants, benzodiazepines and insulin. RESULTS: The prenatally AP-exposed children had 7% more GP contacts than unexposed children, IRR: 1.07 (95% CI: 1.03, 1.11). The association was slightly stronger among children of mothers with no diagnosis of severe psychiatric disorder (IRR: 1.08, 95% CI: 1.04–1.13) than among children of mothers with severe psychiatric disorder (IRR: 1.03, 95% CI: 0.96–1.11), but the difference was not statistically significant. We found no difference between prenatally AP-exposed children and their unexposed siblings, IRR: 1.00 (95% CI: 0.97–1.04) for total contacts. CONCLUSION: Children of women using AP medication in pregnancy had more GP contacts in childhood than children of mothers not using AP medication. However, this might be explained by confounding from maternal behavior and mental illness.
format Online
Article
Text
id pubmed-5716673
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57166732017-12-13 Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark Würtz, Anne Mette Lund Høstrup Vestergaard, Claus Rytter, Dorte Sørensen, Merete Juul Christensen, Jakob Vestergaard, Mogens Bech, Bodil Hammer Clin Epidemiol Original Research BACKGROUND: Antipsychotic (AP) medication is increasingly used for many health conditions. Prenatal exposure to AP medication has been associated with several adverse outcomes, but the findings remain inconsistent. PURPOSE: We aimed to investigate prenatal exposure to AP medication and the use of primary health care system in childhood. SUBJECTS AND METHODS: All live-born singletons in Denmark during 1997–2012 were identified in the nationwide Danish National Patient Register and followed until December 31, 2013 (n = 963,010). Information on prenatal exposure to AP medication was obtained from the Danish Register of Medicinal Product Statistics. Contacts to the general practitioner (GP) were used as a proxy for the overall health of the children. Negative binomial regression was used to calculate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for the association between prenatal exposure to AP medication and number and type of GP contacts, excluding routine well-child visits and vaccinations. The models were adjusted for sex and birth date of the child, maternal age, parity, cohabitation status, income, education, smoking status, diagnosis of substance abuse, severe psychiatric disorder, depression and epilepsy as well as the use of antiepileptic drugs, antidepressants, benzodiazepines and insulin. RESULTS: The prenatally AP-exposed children had 7% more GP contacts than unexposed children, IRR: 1.07 (95% CI: 1.03, 1.11). The association was slightly stronger among children of mothers with no diagnosis of severe psychiatric disorder (IRR: 1.08, 95% CI: 1.04–1.13) than among children of mothers with severe psychiatric disorder (IRR: 1.03, 95% CI: 0.96–1.11), but the difference was not statistically significant. We found no difference between prenatally AP-exposed children and their unexposed siblings, IRR: 1.00 (95% CI: 0.97–1.04) for total contacts. CONCLUSION: Children of women using AP medication in pregnancy had more GP contacts in childhood than children of mothers not using AP medication. However, this might be explained by confounding from maternal behavior and mental illness. Dove Medical Press 2017-12-01 /pmc/articles/PMC5716673/ /pubmed/29238228 http://dx.doi.org/10.2147/CLEP.S145524 Text en © 2017 Würtz et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Würtz, Anne Mette Lund
Høstrup Vestergaard, Claus
Rytter, Dorte
Sørensen, Merete Juul
Christensen, Jakob
Vestergaard, Mogens
Bech, Bodil Hammer
Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark
title Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark
title_full Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark
title_fullStr Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark
title_full_unstemmed Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark
title_short Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark
title_sort prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in denmark
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716673/
https://www.ncbi.nlm.nih.gov/pubmed/29238228
http://dx.doi.org/10.2147/CLEP.S145524
work_keys_str_mv AT wurtzannemettelund prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark
AT høstrupvestergaardclaus prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark
AT rytterdorte prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark
AT sørensenmeretejuul prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark
AT christensenjakob prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark
AT vestergaardmogens prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark
AT bechbodilhammer prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark